Watchlist Price Alert

Regencell Bioscience Lim... (RGC)

NASDAQ: RGC · Real-Time Price · USD

72.23

12.23 (20.38%)

At close: Jun 17, 2025, 2:21 PM

Regencell Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Cash & Equivalents	2.96M	1.56M	6.42M	59.41K	386.98K	243.31K	228.8M	246.5M	219.6M
Short-Term Investments	5M	10M	10M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	97.68K	108.5K	114.3K	191.42K	18.72K	n/a	422.5M	379.4M	373.8M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	184M	155.1M	153.1M
Inventory	n/a	-56.55K	-27.6K	-7.44K	n/a	n/a	22.9M	20.9M	22.4M
Other Current Assets	n/a	56.55K	0.00	n/a	n/a	n/a	27.6M	24.4M	43.1M
Total Current Assets	8.11M	11.62M	16.44M	66.85K	386.98K	243.31K	463.3M	446.9M	438.2M
Property-Plant & Equipment	226.51K	891.91K	1.46M	81.86K	108.32K	n/a	1.51B	1.39B	1.4B
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	389.4M	373M	378.9M
Total Long-Term Assets	324.2K	1M	1.57M	273.29K	127.04K	n/a	2.38B	2.2B	2.19B
Total Assets	8.44M	12.62M	18.02M	340.13K	514.02K	243.31K	2.84B	2.65B	2.63B
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	232.2M	194.8M	229.7M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	186.2M	192.7M	203.4M
Short-Term Debt	n/a	n/a	n/a	3.68M	3.07M	2.08M	26.6M	25.5M	27.4M
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	116.4M	97M	90.8M
Total Current Liabilities	193.58K	606.91K	577.76K	4.34M	3.16M	2.08M	561.4M	510M	551.3M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	2.34B	2.2B	2.23B
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	393.3M	365.2M	315.1M
Total Long-Term Liabilities	25.93K	25.41K	360.27K	n/a	n/a	n/a	3.14B	2.97B	2.96B
Total Liabilities	219.51K	632.32K	938.03K	4.34M	3.16M	2.08M	3.7B	3.48B	3.51B
Total Debt	85.74K	463.67K	771.25K	3.68M	3.07M	2.08M	2.37B	2.22B	2.26B
Common Stock	130.00	130.00	130.00	100.00	100.00	100.00	100K	100K	100K
Retained Earnings	-21.62M	-17.32M	-11.44M	-4M	-2.65M	-1.84M	70.9M	96.5M	64.2M
Comprehensive Income	-45.77K	-86.66K	0.00	n/a	n/a	n/a	-2.24B	-2.15B	-2B
Shareholders Equity	8.22M	12.03M	17.07M	-4M	-2.65M	-1.84M	-855.9M	-839.1M	-877.8M
Total Investments	5M	10M	10M	n/a	n/a	n/a	n/a	n/a	n/a